Comparing blood-thinning drugs after stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study compares four different blood-thinning medications (indobufen, aspirin, cilostazol, and clopidogrel) used to prevent another stroke. Researchers will look at which drug or combination works best and is safest for patients who've had a recent stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You were diagnosed with an acute ischemic stroke (a stroke caused by a blood clot) and treated at Nanfang Hospital between January 2020 and December 2025
- You started one of four specific blood-thinning medications (indobufen, aspirin, cilostazol, or clopidogrel) within 7 days of leaving the hospital
- You have medical records available for at least 1 year after starting the medication
- You do not have a history of bleeding stroke or active bleeding problems
- Your liver and kidney function are acceptable (not severely damaged)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of blood-thinning medicines to see which one is better at preventing another stroke in people who had a stroke without a clear cause. It may help if you had a stroke recently and have certain heart-related risk factors.
This study tests whether guiding antiplatelet medication with a blood test can help prevent another stroke or TIA. It looks at people who have had a mild stroke or high-risk TIA within the last 48 hours.
This trial tests whether giving an antiplatelet medicine (like aspirin) early—within 3 hours of a clot-busting drug—can help prevent another stroke without causing bleeding. It is for people who still have moderate to severe stroke symptoms after the clot-buster and do not have a large artery blockage.
This trial compares two ways to treat a minor acute ischemic stroke: aspirin plus clopidogrel versus an IV clot-busting medicine (alteplase). It aims to see which approach works better and is safer when symptoms start within 4.5 hours.
This trial is testing whether combining aspirin with either cilostazol or clopidogrel is more effective at preventing another stroke after a minor stroke or TIA. It is for people who had their first mild stroke or TIA and started a blood thinner within 24 hours.
This trial tests a combination of two blood thinners (antiplatelet drugs) to see if they work better than one in people who had a mild stroke caused by a narrowed artery in the brain. If you had a recent first stroke and are otherwise healthy, you may be able to join.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.